Jpmorgan Chase & CO Dyne Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 97,514 shares of DYN stock, worth $2.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

97,514

Previous 54,370 79.35%

Holding current value

$2.81 Million

Previous $1.54 Million 123.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$23.65 - $35.63 $1.02 Million - $1.54 Million	43,144 Added 79.35%	97,514 $3.44 Million
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $168,304 - $376,042	12,887 Added 31.07%	54,370 $1.54 Million
Q4 2023 Feb 12, 2024	SELL	$6.62 - $13.64 $1.96 Million - $4.05 Million	-296,691 Reduced 87.73%	41,483 $551,000
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $2.6 Million - $3.69 Million	302,562 Added 849.61%	338,174 $3.03 Million
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $74,577 - $124,850	8,743 Added 32.54%	35,612 $400,000
Q1 2023 May 18, 2023	BUY	$10.88 - $15.0 $264,024 - $364,005	24,267 Added 932.63%	26,869 $309,000
Q1 2023 May 11, 2023	SELL	$10.88 - $15.0 $194,120 - $267,630	-17,842 Reduced 87.27%	2,602 $29,000
Q4 2022 Feb 13, 2023	SELL	$9.37 - $13.8 $218,620 - $321,981	-23,332 Reduced 53.3%	20,444 $237,000
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $60,883 - $128,277	8,456 Added 23.94%	43,776 $557,000
Q2 2022 Aug 11, 2022	BUY	$4.36 - $10.5 $32,534 - $78,351	7,462 Added 26.79%	35,320 $242,000
Q1 2022 May 11, 2022	SELL	$6.52 - $12.27 $65,069 - $122,454	-9,980 Reduced 26.38%	27,858 $268,000
Q4 2021 Feb 10, 2022	SELL	$11.89 - $16.07 $663,997 - $897,429	-55,845 Reduced 59.61%	37,838 $450,000
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $1.46 Million - $2.01 Million	93,683 New	93,683 $1.52 Million

Others Institutions Holding DYN

# of Institutions

205

Shares Held

105M

Call Options Held

82.7K

Put Options Held

24.8K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.49B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Dyne Therapeutics, Inc. Transaction History